Skip to content

Longterm Influence of Pediatric Long COVID Syndrome

Longterm Influence of Pediatric Long COVID Syndrome on the Neuropsychiatric Function, Social Function, Neuroimage, and Gut Microbiota

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05566392
Enrollment
500
Registered
2022-10-04
Start date
2022-10-20
Completion date
2030-12-31
Last updated
2024-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19-Associated Encephalitis, Long COVID

Keywords

pediatric neurology, psychiatric evaluation, Long COVID syndrome, magnetic resonance image

Brief summary

We enroll pediatric patients who were diagnosed COVID-19 for main observation target. We will perform brain MRI and neuropsychiatric evaluation 4-6 months after COVID-19 diagnosed. We also enroll healthy age- and gender-matched participant for cross-over comparison. We will perform same evaluation process one year later for longitudinal evaluation

Interventions

DIAGNOSTIC_TESTBrain MRI

Brain MRI including diffusion spectrum image, and functional MRI Interview with questionnaires for neuropsychiatric evaluation Near infrared spectroscopy and resting-state connectivity evaluation

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 6-18 years old * Has been diagnosed COVID-19 before

Exclusion criteria

* History of neuropsychiatric disorders * Have some device not allowed for MRI

Design outcomes

Primary

MeasureTime frameDescription
Difference between COVID and healthy group1 years after enrollment for primary evaluationThe neuroimage difference between COVID and healthy group and the correlation with neuropsychiatric evaluation

Countries

Taiwan

Contacts

Primary ContactWang-Tso Lee, PHD
leeped@hotmail.com(886)2-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026